Life Sciences
New life sciences findings from Peking Union Medical College described
Published in Blood Weekly, December 6th, 2007
Research findings, 'Intravenous nicorandil preserves endothelial junctions by decreasing endothelin-1 via activation of ATP-sensitive K+ channel,' are discussed in a new report. "It has been verified that nicorandil can attenuate myocardial no-reflow. However; the effects of nicorandil on endothelial junctions and Endothelin-1 (ET-1) are unknown 40 mini-swines randomized into 5 study groups: 8 in control, 8 nicorandil pretreatment, 8 in glibenclamide (KATP channel blocker)-treated, 8 in nicorandil and glibenclamide-pretreated and 8 in sham-operated," scientists in Beijing, People's Republic of China report.
"Acute myocardial infarction and reperfusion model was created...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-12-06)
More Articles from Blood Weekly
- Acute Pancreatitis
Data on acute pancreatitis detailed by researchers at University of Ghent - Acute Pancreatitis
New acute pancreatitis study findings have been reported by researchers at University Hospital - Acute Pancreatitis
Research findings from Kobe University update understanding of acute pancreatitis - Cancer Vaccines
New research on cancer vaccines from Osaka University summarized - Clinical Trial Research
Kiadis Pharma Continues to Provide Rhitol to Participating Physicians During Completion of Current Clinical Study - Congestive Heart Failure
Data on congestive heart failure reported by researchers at University of Chicago - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
